Cochlear Limited Gets FDA Approval for Nucleus 5

Pharmabiz.com -- Cochlear Limited, the global leader in cochlear and bone conduction implant technology, announced that it will launch three new technologies - Cochlear Nucleus 5, Cochlear Baha BP100 and Cochlear Hybrid - in India within a month. Trials of these products were already conducted over the period of 10 years in India. Already 3500 hearing impaired patients are the recipients of these implant technologies in the country.